Back to Results

Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Memorial Hospital Central
Memorial Hospital North
Pikes Peak Regional Hospital

Principal Investigator
Uchenna Njiaju

Uchenna Njiaju

Study ID

Protocol Number: 19-6509

More information available at ClinicalTrials.gov: NCT03975647

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers